GENETIC EPIDEMIOLOGY OF PD--MITOCHONDRIAL INHERITANCE

PD遗传流行病学--线粒体遗传

基本信息

  • 批准号:
    6664102
  • 负责人:
  • 金额:
    $ 23.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-08-01 至 2003-07-31
  • 项目状态:
    已结题

项目摘要

The main scientific theme of this project is to determine if the genetic epidemiology of Parkinson's disease (PD) is consistent with an etiologic role for inherited abnormalities of mitochondrial DNA (mtDNA). The presence of a mitochondrial complex I defect in subjects with PD is now well established. Furthermore, this defect appears to arise as a consequence of abnormalities in mtDNA. Whether these abnormalities of mtDNA are acquired or inherited is not known, but we have recently shown in a multi-generational family with PD in which transmission has been exclusively along maternal lines that maternal offspring have lower Complex I activity than paternal offspring. In Project 3 we will use data on family history of PD in PD subjects and controls generated by the Subject Accrual and Ascertainment component of the Core. These data will be examined to test three hypotheses regarding the role of mtDNA mutations in particular, and genetic risk factors in general, in the etiology of PD. Hypothesis 1: There is a predominance of maternal inheritance in PD. If inherited mtDNA mutations play a role in PD etiology, one would predict an excess of maternal inheritance. We will compare directly the number of affected mothers and fathers of probands using survival analysis. Logistic regression will be used to evaluate the influence of the gender of affected parents when probands have both an affected sibling and an affected parent, and to determine the relative risk of developing PD between PD subjects and controls when there is an affected mother versus an affected father. Hypothesis 2: Parkinson's disease susceptibility is determined by a major gene. We will perform a complex segregation analysis of a series of consecutively ascertained nuclear genetic families. Hypothesis 3: Certain disease characteristics of PD may be associated with familial or non-familial PD. Using logistic regression and analysis of variance, we will address the question of whether early age of onset, gender, or rapid symptom progression in PD is associated with a positive family history.
该项目的主要科学主题是确定帕金森病(PD)的遗传流行病学是否与线粒体DNA(mtDNA)遗传异常的病因学作用一致。线粒体复合物I缺陷的存在下,与PD的主题是现在很好地建立。此外,这种缺陷似乎是mtDNA异常的结果。这些mtDNA的异常是获得性的还是遗传性的尚不清楚,但我们最近在一个多代PD家族中发现,在该家族中,遗传完全是沿着母系进行的,母系后代的复合体I活性低于父系后代。在项目3中,我们将使用由核心的受试者累积和确定部分生成的PD受试者和对照的PD家族史数据。这些数据将被检查,以测试三个假设的作用,特别是线粒体DNA突变,一般遗传危险因素,在PD的病因。假设1:PD中母系遗传占优势。如果遗传性mtDNA突变在PD病因中起作用,则可以预测母体遗传过多。我们将使用生存分析直接比较先证者的患病母亲和父亲的数量。当先证者有受影响的兄弟姐妹和受影响的父母时,将使用逻辑回归来评估受影响父母的性别的影响,并确定当有受影响的母亲与受影响的父亲时,PD受试者和对照者之间发生PD的相对风险。假设2:帕金森病的易感性是由一个主基因决定的。我们将对一系列连续确定的核心遗传家系进行复杂的分离分析。假设3:PD的某些疾病特征可能与家族性或非家族性PD相关。使用logistic回归和方差分析,我们将解决的问题,是否发病年龄,性别,或快速症状进展的PD与阳性家族史。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE F WOOTEN其他文献

GEORGE F WOOTEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE F WOOTEN', 18)}}的其他基金

CORE--CLINICAL, MOLECULAR GENETICS & DATA MANAGEMENT
核心——临床、分子遗传学
  • 批准号:
    6664104
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
Parkinson's Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验
  • 批准号:
    6797316
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
Parkinson's Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验
  • 批准号:
    6660782
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
Parkinson's Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验
  • 批准号:
    7555448
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
Parkinson's Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验
  • 批准号:
    8033154
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
Parkinson's Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验
  • 批准号:
    6544965
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
CORE--CLINICAL, MOLECULAR GENETICS & DATA MANAGEMENT
核心——临床、分子遗传学
  • 批准号:
    6618258
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
GENETIC EPIDEMIOLOGY OF PD--MITOCHONDRIAL INHERITANCE
PD遗传流行病学--线粒体遗传
  • 批准号:
    6618256
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
Parkinson's Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验
  • 批准号:
    7012684
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:
Parkinson's Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验
  • 批准号:
    7157550
  • 财政年份:
    2002
  • 资助金额:
    $ 23.19万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.19万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 23.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了